Detailed FundamentalsSingle-page fundamentals layout — broad valuation, growth, profitability, health, competitors, top funds & analyst detail.
Price chartUnavailable
Loading price history...
52-Week Range
Trailing twelve months
$65.00$77.39
1-Month Range
Month down -7.1%
$68.53$76.94
Daily Price Range
Day down -1.5%
$70.96$72.16
Volume
vs 5M avg
6244505M avg
Profile
Identity and capital structure
SectorUnclassified
IndustryCommon Stock
Market Cap$47.7B
Short % of Float—
Employees—
Sales$17,401M
Shares Outstanding667,302,930
IPO Date—
Last Reported Qtr.—
Next Qtr. Report—
Headquarters—
Homepagewww.vylr.com
Vylor Inc. — Vylor Inc. operates as a seed and genetics company. It delivers a pipeline in the industry's elite germplasm and transformative sciences, such as biotechnology and gene editing. The company was founded in 1802 and is based in Johnston, Iowa..· via yahoo
Warnings
2 signals
Live
- ROE below 5% (4.3%)
- Negative revenue growth (-1.2%)
Scores
0–100 · higher is better except where noted · Insider Sent: directional buy ratio (excl. gifts/grants)
Value
63
Growth
72
Quality
43
Sentiment
67
Insider Sent.
—
Piotroski F
—
Altman Z
—
Consensus rating unavailable — no analyst coverage on file for VYLR.
Price targets unavailable — no 12-month targets on file for VYLR.
Valuation Engine
DCF Intrinsic Valuation Model
Run an interactive 5-year Discounted Cash Flow valuation on VYLR, calculate Margin of Safety, and stress-test WACC discount hurdles.
RetrievedQuote: Live · Insiders: Live · Fundamentals/Benchmarks: Curated · Vantage Composite · 2 warnings surfacedNov 11, 2026, 6:09 PM UTC